Ropes & Gray advised uniQure N.V. on the deal. uniQure N.V. signed an agreement to sell a portion of the royalty rights due to uniQure from biopharmaceutical...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Amarin Corporation plc on the deal. Pharmaceutical company Amarin Corporation plc announced an agreement with CSL Seqirus for an exclusive license and distribution...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for the treatment of cancer, announced a global, multi-year...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Takeda Pharmaceutical Company Limited in the deal. Takeda Pharmaceutical Company Limited announced an exclusive collaboration and license agreement with JCR Pharmaceuticals Co.,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Shape Therapeutics in the deal. Shape Therapeutics entered into a strategic research collaboration and license agreement with Roche worth up to $3...
You must be a Standard 1 Year member to access this content.
